XELJANZ 11 mg prolonged-release tablets

Company
Pfizer Healthcare Ireland Unlimited Company
Active Ingredient
Dosage Form
Prolonged-release tablet
Legal Category
A - prescription, may not be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/17/1178/010 11 milligram(s) L04AF01 Prolonged-release tablet
EU/1/17/1178/011 11 milligram(s) L04AF01 Prolonged-release tablet
EU/1/17/1178/012 11 milligram(s) L04AF01 Prolonged-release tablet
EU/1/17/1178/013 11 milligram(s) L04AF01 Prolonged-release tablet
Licence number
EU/1/17/1178/010
Strength
11 milligram(s)
ATC Code
L04AF01
Dosage Form
Prolonged-release tablet
Licence number
EU/1/17/1178/011
Strength
11 milligram(s)
ATC Code
L04AF01
Dosage Form
Prolonged-release tablet
Licence number
EU/1/17/1178/012
Strength
11 milligram(s)
ATC Code
L04AF01
Dosage Form
Prolonged-release tablet
Licence number
EU/1/17/1178/013
Strength
11 milligram(s)
ATC Code
L04AF01
Dosage Form
Prolonged-release tablet

Pfizer Healthcare Ireland Unlimited Company

The Watermarque Building, Ringsend Road, Dublin 4, D04 K7N3, Ireland, D04 K7N3 Dublin

Website
https://www.pfizermedicalinformation.ie/
Telephone
+3531800633363